ST8SIA6 and breast cancer: Recently, ST8SIA6-AS1 has garnered attention due to its abnormal expression and oncogenic role in multiple types of tumor progression, including pituitary adenoma (Yin et al., 2021; Li et al., 2022), breast cancer (Jeong et al., 2018; Fang et al., 2020; Luo et al., 2020; Chen et al., 2021; Qiao et al., 2022), cholangiocarcinoma (He et al., 2021), lung cancer (Cao et al., 2020; Wang et al., 2023), and colorectal cancer (Huang CM.